Credit Agricole S A Has $10.05 Million Holdings in Omega Healthcare Investors, Inc. $OHI

Key Points

• Credit Agricole S A reduced its stake in Omega Healthcare Investors by 36.3%, now holding $10.05 million in shares after selling 150,201 during Q1.
• Omega Healthcare Investors reported a net margin of 42.23% with a earnings per share (EPS) of $0.77 for the latest quarter, surpassing expectations.
• The company announced a quarterly dividend of $0.67, which translates to an annual yield of 6.3%, despite a high dividend payout ratio of 165.43%.

Credit Agricole S A cut its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 36.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 264,028 shares of the real estate investment trust's stock after selling 150,201 shares during the quarter. Credit Agricole S A owned 0.09% of Omega Healthcare Investors worth $10,054,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in OHI. NBC Securities Inc. bought a new position in Omega Healthcare Investors during the 1st quarter worth $29,000. Dunhill Financial LLC grew its holdings in shares of Omega Healthcare Investors by 97.9% during the 4th quarter. Dunhill Financial LLC now owns 1,516 shares of the real estate investment trust's stock worth $57,000 after purchasing an additional 750 shares in the last quarter. CoreCap Advisors LLC grew its holdings in shares of Omega Healthcare Investors by 177.3% during the 4th quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust's stock worth $60,000 after purchasing an additional 1,009 shares in the last quarter. Park Square Financial Group LLC acquired a new stake in shares of Omega Healthcare Investors during the 4th quarter worth $61,000. Finally, UMB Bank n.a. increased its position in shares of Omega Healthcare Investors by 94.9% in the first quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock worth $83,000 after purchasing an additional 1,059 shares during the period. 65.25% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently weighed in on OHI. Royal Bank Of Canada upped their price objective on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a "sector perform" rating in a research report on Thursday, August 7th. Wells Fargo & Company raised shares of Omega Healthcare Investors from an "equal weight" rating to an "overweight" rating and upped their price target for the stock from $38.00 to $41.00 in a report on Monday, July 14th. Four investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $42.00.

Insider Activity

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company's stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the transaction, the director directly owned 18,654 shares in the company, valued at approximately $749,144.64. This represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.50% of the company's stock.

Omega Healthcare Investors Stock Performance

NYSE:OHI opened at $42.3350 on Friday. Omega Healthcare Investors, Inc. has a twelve month low of $35.04 and a twelve month high of $44.42. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. The stock's 50-day simple moving average is $38.40 and its 200 day simple moving average is $37.58. The firm has a market capitalization of $12.49 billion, a PE ratio of 26.13, a price-to-earnings-growth ratio of 2.22 and a beta of 0.66.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last posted its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm had revenue of $235.60 million during the quarter, compared to analysts' expectations of $248.49 million. During the same quarter in the prior year, the business earned $0.71 earnings per share. The business's revenue for the quarter was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were given a $0.67 dividend. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.3%. Omega Healthcare Investors's dividend payout ratio (DPR) is currently 165.43%.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.